Muir-Torre Syndrome: A Case Report and a Literature Review of Genetic Insights and Cancer Surveillance

• Published in: Curēus (Palo Alto, CA) Vol. 16; no. 7; p. e65828
• Main Authors: Trehan, Shubam, Singh, Gurjot, Goswami, Kanishka, Farooq, Amna, Kalpana, Fnu, Antil, Priya, Azhar, Waqas
• Format: Journal Article
• Language: English
• Published: United States 31-07-2024
• Subjects: cancer surveillance; muir torre syndrome; actinic lesions; msh2; sebaceous carcinoma in situ; msh6; visceral neoplasms
• ISSN: 2168-8184; 2168-8184
• DOI: 10.7759/cureus.65828

Muir-Torre syndrome (MTS) is a rare autosomal dominant genetic disorder that manifests through the co-occurrence of sebaceous skin tumors and internal malignancies, primarily due to mutations in mismatch repair (MMR) genes such as MSH2, MLH1, and MSH6. This paper presents a detailed case report of a 57-year-old female diagnosed with MTS, highlighting her extensive medical history and the critical role of genetic testing and multidisciplinary management. The patient's dermatological and oncological assessments revealed multiple sebaceous carcinomas and recurrent urothelial carcinoma, confirmed by a pathogenic MSH2 mutation. Through comprehensive preventive surgeries and rigorous follow-up, this case underscores the necessity of proactive cancer surveillance. The discussion integrates findings from key genetic studies and emphasizes the importance of immunohistochemistry in diagnosis. Recommendations for clinical practice include routine genetic testing, stringent surveillance, and multidisciplinary management, underscoring the need for ongoing research to understand better and manage this complex syndrome.